Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation

Winnie S Wang1, Joseph D Ma1, Sandahl H Nelson1

  • 1University of California, San Diego, San Diego, CA.

Insights

Advance care planning (ACP) and palliative care (PC) integration in hematopoietic stem-cell transplantation (HSCT) showed low outpatient code status documentation and limited PC/hospice use. Further research is needed to improve these crucial aspects of HSCT care.

Area of Science:

  • Hematology
  • Oncology
  • Palliative Care

Background:

  • Advance care planning (ACP) in hematopoietic stem-cell transplantation (HSCT) is complex due to the potential for cure alongside significant morbidity and mortality risks.
  • Integrating palliative care (PC) is essential for managing complex symptoms and improving quality of life in HSCT patients.

Purpose of the Study:

  • To evaluate the integration of advance care planning and palliative care for patients undergoing hematopoietic stem-cell transplantation.
  • To assess the documentation of code status, advance directives, and utilization of PC and hospice services in HSCT patients.

Main Methods:

  • Retrospective analysis of electronic medical records for HSCT patients (January 2011-December 2015).
  • Exclusion criteria included multiple transplants and age under 18.
  • Primary objective: setting and clinician specialty for initial/final code status documentation. Secondary objectives: advance directive/Physician Orders for Life-Sustaining Treatment completion, PC consultation, hospice enrollment, and place of death.

Main Results:

  • The study included 602 HSCT patients (39% allogeneic, 61% autologous).
  • Code status documentation was high (99.2% initially full code), but outpatient documentation was low (3% initial, 24% final).
  • Palliative care consultation occurred in 19% of patients, primarily in-hospital. Advance directive completion was associated with allogeneic transplant type and age. Hospice enrollment was low (15%), with most deaths (85%) occurring in-hospital.

Conclusions:

  • This single-center study highlights low outpatient code status documentation and underutilization of palliative care and hospice services among HSCT patients.
  • There is a need to improve the integration of advance care planning and palliative care throughout the HSCT journey, particularly in outpatient settings.
Abstract

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
Planning Nursing Care I01:21

Planning Nursing Care I

The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...
6.2K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K